These data provide evidence that, under ischemic conditions, adiponectin improves endothelial function through LRP1/CRT-mediated increases in COX-2 signaling, and implicate this regulatory axis in the pathogenesis of obesity-related vascular diseases (126). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.